Series of rare side effects underscores the need to track targeted anti-cancer drugs

Series of rare side effects underscores the need to track targeted anti-cancer drugs

Series of rare side effects underscores the need to track targeted anti-cancer drugs

Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a trauma surgeon. Working with lung cancer patients at University of Colorado Cancer Center, they both, independently, noticed something strange: